AMSBIO has announced a package of initiatives to support the Glycobiology research community following the recent announcement by Seikagaku Corporation that they plan to discontinue their research reagents and glycobiology biochemicals business as of September 30th 2011.
As a specialist in high purity reagents for glycobiology and glycoanalysis for over 20 years - AMSBIO has developed in-depth technical expertise and a broad range of products including a range of antibodies, enzymes, assays and standards for Proteoglycan and Glycosaminoglycan (GAG) research.
Alex Sim, CEO of AMSBIO commented: "To support users of Seikagaku research reagents, GAG antibodies and biochemicals, we have invested in inventory to enable us to supply researchers for the next 18-24 months."
He added: "In addition we are actively working on alternative products and to maintain our global reputation as being the premier supplier for Glycobiology research".
For more information, visit www.amsbio.com
Science news and opinion for scientists in food safety, laboratory science, human genetics, biotechnology, drug discovery, spectroscopy and chromatography.
FREE NewsBrief
RSS Feed
Get the Scientist Live RSS Feed

ITCM is a global manufacturer and leading innovator in customised machinery and systems for pharmaceutical packaging and processing.
Landauer specialist cosmetic surgery and weight loss surgery Providers of surgery from breast enlargement to liposuction across the UK
View digital magazineImaging
Simultaneous imaging and photodynamic therapy of cancer
Using 3D imaging to improve the lives of lung disease patients
Cell Cultures
Fruit flies provide new knowledge about uninhibited cell growth
Stem cell researchers map new knowledge about insulin production
Automation
An environmentally friendly robot
3D characterization of powder gas stream improves process quality in laser material deposition
Biotechnology




















